Botanical species · safety record

Rumex alpinus

The EFSA Compendium of Botanicals holds 9 constituent measurements for Rumex alpinus. This page reports what those source records contain and how to reach them. It carries no effect estimate, no dose and no recommendation.

Accepted name in source: Rumex alpinus L.

9Constituent measurements

0Safety records

6Cited sources

0Licensed products (Canada)

Regulatory presence

No Health Canada licensed natural health product in the snapshot names this species as a medicinal ingredient under this exact binomial. Absence here means absence from this one register under this one name, not absence from trade, and not a safety verdict.

What the records describe

Constituents measured

Plant parts

Preparations

Recorded constituents

What analytical work has found in this species, at which plant part and preparation. A measured constituent is a fact about material, not about effect.

Substance	Plant part	Preparation	Concentration	Analytical method	Source
Anthraquinones	Aerial part of plants	Solvent extraction	—	HPLC-UV	Resolve DOI
Chrysophanol	Leaves	Solvent extraction	—	Standard Chromatographic tests (paper- thin layer- and column chromatography)	Resolve DOI
Emodin	Leaves	Solvent extraction	—	Standard Chromatographic tests (paper- thin layer- and column chromatography)	Resolve DOI
Physcion	Unspecified	—	—	Nuclear Magnetic Resonance (NMR)	Resolve DOI
Aloe-emodin	Unspecified	Solvent extraction	—	Standard Chromatographic tests (paper- thin layer- and column chromatography)	No resolvable identifier
Anthraquinones	Roots and other underground parts	—	≤ 2.5 Percent	Unspecified	No resolvable identifier
Anthraquinones	Roots and other underground parts	—	≥ 2 Percent	Unspecified	No resolvable identifier
Chrysophanol	Unspecified	Solvent extraction	1.57 Percent	Standard Chromatographic tests (paper- thin layer- and column chromatography)	No resolvable identifier
Rhein	Unspecified	Solvent extraction	—	Standard Chromatographic tests (paper- thin layer- and column chromatography)	No resolvable identifier

Cited sources

The literature the compendium cites for this species. Metatron Health has no relationship with these authors or journals and earns nothing from citing them.

LEISTNER, E. SECOND PATHWAY LEADING TO ANTHRAQUINONES IN HIGHER PLANTS. Phytochemistry, 1971, vol. 10, no. 12, p. 3015-&. DOI
Babulka, Peter., Nyiredy, S., Verzar Petri, G. Particulars on the cultivation of Rumex alpinus L. in Hungary. Herba hungarica, 1982, vol. 21(2-3), p. 85-97.
Sibul, Filip S., Orcic, Dejan Z., Svircev, Emilija., Mimica-Dukic, Neda M. Optimization of extraction conditions for secondary biomolecules from various plant species . Hemijska industrija, 2016, vol. 70, no. 4, p. 473-483. DOI
Romanova, A. S., Ban'kovskii, A. I. Natural sources for obtaining chrysarobin. Meditsinskaya promyshlennost sssr, 1961, vol. 15(No. 1), p. 16-21.
Chubinidze, G. D., Turabelidze, D. G., Tsitsishvili, V. G., Kikoladze, V. S. Carbon-13 NMR study of anthraquinone derivatives from Rumex alpinus. Khimiya prirodnykh soedinenii, 1987, vol. (6), p. 908-9.
Chubinidze, G.D., Turabelidze, D.G., Tsitsishvili, V.G., Kikoladze, V.S. 13C NMR spectral analysis of anthraquinone derivatives from Rumex alpinus. Chemistry of natural compounds, 1987, vol. 23, no. 6, p. 762-763. DOI

Boundary

A constituent measurement is a fact about material at a stated preparation, not a statement about what that material does in a person. An adverse-effect or genotoxicity record is an observation reported in a source, most often in an animal or laboratory model. Neither is a Metatron Health conclusion about causality, human risk or benefit, and the absence of a record is not proof that a preparation is safe. Nothing here is diagnosis, prescribing or individual medical care.

Continue

Independent literature